|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:Grail,_Inc.
|
|
gptkbp:acquisitionYear
|
2021
|
|
gptkbp:CEO
|
gptkb:Jacob_Thaysen
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:focus
|
genomics
personalized medicine
genetic sequencing
|
|
gptkbp:founded
|
1998
|
|
gptkbp:founder
|
gptkb:Anthony_A._Czarnik
gptkb:Anthony_Czarnik
gptkb:John_Stuelpnagel
gptkb:Larry_Bock
gptkb:Mark_Chee
gptkb:David_Walt
|
|
gptkbp:headquartersLocation
|
gptkb:San_Diego,_California,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Illumina Inc.
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:ISIN
|
US4523271090
|
|
gptkbp:keyPerson
|
gptkb:Robert_Nelsen
gptkb:Frances_Arnold
gptkb:John_W._Thompson
gptkb:Scott_Gottlieb
gptkb:Francis_deSouza
gptkb:Jacob_Thaysen
gptkb:Gary_S._Guthart
gptkb:Caroline_Dorsa
gptkb:Philip_A._Sharp
gptkb:Robert_S._Epstein
gptkb:Sam_Samad
|
|
gptkbp:marketCap
|
over $30 billion (2023)
|
|
gptkbp:netIncome
|
$-4.4 billion (2022)
|
|
gptkbp:notableEvent
|
European Commission ordered divestiture of Grail (2023)
FTC ordered divestiture of Grail (2023)
|
|
gptkbp:notableProduct
|
gptkb:HiSeq
gptkb:MiSeq
gptkb:NextSeq
gptkb:NovaSeq
gptkb:iSeq
|
|
gptkbp:numberOfEmployees
|
approximately 9,100 (2023)
|
|
gptkbp:products
|
DNA sequencing
genetic analysis
genotyping arrays
|
|
gptkbp:publiclyTraded
|
true
|
|
gptkbp:revenue
|
$4.5 billion (2022)
|
|
gptkbp:stockExchange
|
gptkb:NASDAQ-100
gptkb:S&P_500
|
|
gptkbp:stockSymbol
|
gptkb:ILMN
|
|
gptkbp:subsidiary
|
gptkb:Grail,_Inc.
|
|
gptkbp:tradedOn
|
gptkb:NASDAQ:_ILMN
|
|
gptkbp:website
|
https://www.illumina.com/
|
|
gptkbp:bfsParent
|
gptkb:^NDX
|
|
gptkbp:bfsLayer
|
6
|